PDF Archive search engine
Last database update: 11 May at 07:47 - Around 76000 files indexed.

Show results per page

Results for «betmiga»:

Total: 1 results - 0.006 seconds

BetmigaTest 100%

BETMIGA IS AN ENTIRELY NEW APPROACH TO OAB Betmiga is the first ß3-adrenoceptor agonist licensed to treat OAB.1 • A once-daily tablet that works differently to antimuscarinics1,2 • Relaxes the bladder during the storage phase via stimulation of ß3-adrenergic receptors in the detrusor muscle1 • Improves storage capacity and inter-void interval, without impeding voluntary voiding1 Mode of action of OAB treatments2 PARASYMPATHETIC SYMPATHETIC (Adrenergic control ) (Cholinergic control) Activates ß3-adrenergic receptor Blocks muscarinic receptor Detrusor muscle wall Antimuscarinics Increases relaxation Inhibits involuntary contractions Delayed voiding Bladder ß3-adrenoceptor agonist (Betmiga) Increased storage capacity + inter-void interval Adapted from Chu et al., 2006.